A Phase I Study of AMG386 (IND#114215) an Angiopoeitin Neutralizing Peptibody in Children with Relapsed or Refractory Solid Tumors Including CNS Tumors
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
We are testing a new experimental drug in the hopes of finding a drug that may be effective against tumors that have come back or that have not responded to standard therapy.
Description
We are testing a new experimental drug in the hopes of finding a drug that may be effective against tumors that have come back or that have not responded to standard therapy.
Details
| Condition | Solid Tumors, CNS Tumors |
|---|---|
| Age | 1years - 21years |
| Clinical Study Identifier | TX2454 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.